The Zhitong Finance App learned that according to media reports quoting people familiar with the matter, Apollo Global Management (APO.US), a global alternative asset management company, is in talks to acquire DePuy Synthes, the orthopedic business division of Johnson & Johnson (JNJ.US). The deal could value the business at close to $20 billion. The report said the agreement could be reached within the next few weeks. The report also added that while the business has attracted the interest of many private equity firms, the pharmaceutical giant may also decide to split the division as an independent listed company.

The Zhitong Finance App learned that according to media reports quoting people familiar with the matter, Apollo Global Management (APO.US), a global alternative asset management company, is in talks to acquire DePuy Synthes, the orthopedic business division of Johnson & Johnson (JNJ.US). The deal could value the business at close to $20 billion. The report said the agreement could be reached within the next few weeks. The report also added that while the business has attracted the interest of many private equity firms, the pharmaceutical giant may also decide to split the division as an independent listed company.